Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 230

1.

Quantitative analysis of C4b dimer binding to distinct sites on the C3b/C4b receptor (CR1).

Reilly BD, Makrides SC, Ford PJ, Marsh HC Jr, Mold C.

J Biol Chem. 1994 Mar 11;269(10):7696-701.

2.

Cell surface expression of the C3b/C4b receptor (CR1) protects Chinese hamster ovary cells from lysis by human complement.

Makrides SC, Scesney SM, Ford PJ, Evans KS, Carson GR, Marsh HC Jr.

J Biol Chem. 1992 Dec 5;267(34):24754-61.

3.

A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway.

Scesney SM, Makrides SC, Gosselin ML, Ford PJ, Andrews BM, Hayman EG, Marsh HC Jr.

Eur J Immunol. 1996 Aug;26(8):1729-35.

PMID:
8765013
4.

Binding of C3b and C4b by the CR1-like site in murine CR1.

Kalli KR, Fearon DT.

J Immunol. 1994 Mar 15;152(6):2899-903.

PMID:
8144890
5.

Sites within the complement C3b/C4b receptor important for the specificity of ligand binding.

Krych M, Hourcade D, Atkinson JP.

Proc Natl Acad Sci U S A. 1991 May 15;88(10):4353-7.

6.

Analysis of the functional domains of complement receptor type 1 (C3b/C4b receptor; CD35) by substitution mutagenesis.

Krych M, Clemenza L, Howdeshell D, Hauhart R, Hourcade D, Atkinson JP.

J Biol Chem. 1994 May 6;269(18):13273-8.

7.

Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46.

Iwata K, Seya T, Yanagi Y, Pesando JM, Johnson PM, Okabe M, Ueda S, Ariga H, Nagasawa S.

J Biol Chem. 1995 Jun 23;270(25):15148-52.

8.
10.

C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.

Tas SW, Klickstein LB, Barbashov SF, Nicholson-Weller A.

J Immunol. 1999 Nov 1;163(9):5056-63.

12.

Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.

Klickstein LB, Bartow TJ, Miletic V, Rabson LD, Smith JA, Fearon DT.

J Exp Med. 1988 Nov 1;168(5):1699-717.

14.

Mapping of the sites responsible for factor I-cofactor activity for cleavage of C3b and C4b on human C4b-binding protein (C4bp) by deletion mutagenesis.

Fukui A, Yuasa-Nakagawa T, Murakami Y, Funami K, Kishi N, Matsuda T, Fujita T, Seya T, Nagasawa S.

J Biochem. 2002 Nov;132(5):719-28.

15.

A soluble recombinant multimeric anti-Rh(D) single-chain Fv/CR1 molecule restores the immune complex binding ability of CR1-deficient erythrocytes.

Oudin S, Libyh MT, Goossens D, Dervillez X, Philbert F, Réveil B, Bougy F, Tabary T, Rouger P, Klatzmann D, Cohen JH.

J Immunol. 2000 Feb 1;164(3):1505-13.

16.

Murine C4b-binding protein. Mapping of the ligand binding site and the N-terminus of the pre-protein.

Ogata RT, Mathias P, Bradt BM, Cooper NR.

J Immunol. 1993 Mar 15;150(6):2273-80.

PMID:
8450212
17.
18.

Identification of complement receptor type 1-related proteins on primate erythrocytes.

Nickells MW, Subramanian VB, Clemenza L, Atkinson JP.

J Immunol. 1995 Mar 15;154(6):2829-37.

PMID:
7876553
19.

Identification of complement regulatory domains in human factor H.

Gordon DL, Kaufman RM, Blackmore TK, Kwong J, Lublin DM.

J Immunol. 1995 Jul 1;155(1):348-56.

PMID:
7541419

Supplemental Content

Support Center